Elevated ABCB1 Expression Confers Acquired Resistance to Aurora Kinase Inhibitor GSK-1070916 in Cancer Cells
The emergence of multidrug resistance (MDR) has been a major issue for effective cancer chemotherapy as well as targeted therapy. One prominent factor that causes MDR is the overexpression of ABCB1 transporter. In the present study, we revealed that the Aurora kinase inhibitor GSK-1070916 is a subst...
Saved in:
Main Authors: | Zhuo-Xun Wu (Author), Yuqi Yang (Author), Jing-Quan Wang (Author), Wen-Min Zhou (Author), Junyu Chen (Author), Yi-Ge Fu (Author), Ketankumar Patel (Author), Zhe-Sheng Chen (Author), Jian-Ye Zhang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Resistance of Cancer Cells to Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, is Mediated by the ABCB1 Transporter
by: Han Fu, et al.
Published: (2022) -
Impairing the maintenance of germinative cells in Echinococcus multilocularis by targeting Aurora kinase.
by: Zhe Cheng, et al.
Published: (2019) -
Aurora Kinase A Regulation by Cysteine Oxidative Modification
by: In-Gyun Lee, et al.
Published: (2023) -
Emerging roles of Aurora-A kinase in cancer therapy resistance
by: Dayong Zheng, et al.
Published: (2023) -
The significant others of aurora kinase a in cancer: combination is the key
by: Kumar Nikhil, et al.
Published: (2024)